光动力疗法治疗口腔白斑疗效影响因素研究进展

doi:10.13701/j.cnki.kqyxyj.2022.04.002

口腔医学研究 ›› 2022, Vol. 38 ›› Issue (4): 304-307.DOI: 10.13701/j.cnki.kqyxyj.2022.04.002

光动力疗法治疗口腔白斑疗效影响因素研究进展

赵进进¹, 蔡扬^2*

1.贵州医科大学口腔医学院贵州贵阳 550004;
2.贵州医科大学附属口腔医院牙周黏膜科贵州贵阳 550004

收稿日期:2021-05-12 出版日期:2022-04-28 发布日期:2022-04-22
通讯作者: *蔡扬,E-mail:caiyang85@163.com
作者简介:赵进进(1993~ ),女,贵州毕节人,硕士在读,主要从事口腔黏膜学相关研究。
基金资助:
国家自然科学基金(编号:81460104)

Research Progress on Factors Influencing the Curative Effect of Photodynamic Therapy for Oral Leukoplakia

ZHAO Jinjin¹, CAI Yang^2*

1. School of Stomatology, Guizhou Medical University, Guiyang 550004, China;
2. Department of Periodontal & Mucosa Diseases, The Affiliated Stomatology Hospital of Guizhou Medical University, Guiyang 550004, China

Received:2021-05-12 Online:2022-04-28 Published:2022-04-22

摘要/Abstract

摘要： 口腔白斑(oral leukoplakia,OLK)指发生于口腔黏膜上以过度角化为主的白色损害,是口腔常见的潜在恶性疾病。现阶段治疗方式多样,其中光动力作为一项新兴、微创的药械连用技术,在治疗口腔白斑方面不仅前景广阔且可行性高。本文对光动力疗法的基本原理、治疗要素及影响白斑疗效相关因素作一综述。

关键词: 光动力疗法, 白斑

Abstract: Oral leukoplakia is defined as the white lesions on the oral mucosa, mainly characterized by hyperkeratosis, which is the most common potential malignant disease of the oral cavity. At present, there are various treatment methods, among which photodynamic therapy as a novel minimally invasive technique with combined use of drugs and devices, is promising and highly feasible in the treatment of oral leukoplakia. In this paper, the basic principle of photodynamic therapy, treatment factors, and relevant factors affecting the efficacy of leukoplakia were reviewed.

Key words: photodynamic therapy, oral leukoplakia

赵进进, 蔡扬. 光动力疗法治疗口腔白斑疗效影响因素研究进展[J]. 口腔医学研究, 2022, 38(4): 304-307.

ZHAO Jinjin, CAI Yang. Research Progress on Factors Influencing the Curative Effect of Photodynamic Therapy for Oral Leukoplakia[J]. Journal of Oral Science Research, 2022, 38(4): 304-307.

参考文献

[1] 中华口腔医学会口腔黏膜病专业委员会.口腔白斑病的定义与分级标准(试行)[J].中华口腔医学杂志,2011,46(10):579-580.
[2] 沙桐,张伟.氧化应激对潜在口腔恶性疾病作用的研究进展[J].口腔医学研究,2021,37(2):109-112.
[3] Amagasa T, Yamashiro M, Uzawa N. Oral premalignant lesions: from a clinical perspective[J]. Int J Clin Oncol, 2011, 16(1): 5-14.
[4] Ganesh D, Sreenivasan P, Öhman J, et al. Potentially malignant oral disorders and cancer transformation[J]. Anticancer Res, 2018, 38(6):3223-3229.
[5] 韩晓博,郑英虹,杨力明.光敏剂在光动力治疗中的研究进展[J].上海大学学报(自然科学版),2017,23(2):169-178.
[6] Chen Q, Dan H, Tang F, et al. Photodynamic therapy guidelines for the management of oral leucoplakia[J]. Int J Oral Sci, 2019, 11(2):103-107.
[7] Li Y, Wang B, Zheng S, et al. Photodynamic therapy in the treatment of oral leukoplakia: A systematic review[J]. Photodiagnosis Photodyn Ther, 2019, 25(3): 17-22.
[8] Kwiatkowski S, Knap B, Przystupski D, et al. Photodynamic therapy-mechanisms,photosensitizers and combinations[J]. Biomed Pharmacother, 2018, 106(10):1098-1107.
[9] 李亚楠,王怡乔,潘铁成,等.肿瘤光动力疗法——作用机制[J].中国激光医学杂志,2014,23(1):39-48.
[10] Sorrin AJ, Kemal Ruhi M, Ferlic NA, et al. Photodynamic therapy and the biophysics of the tumor microenvironment[J]. Photochem Photobiol, 2020, 96(2):232-259.
[11] 万勃,邓文婷.光动力疗法的研究进展[J].广东化工,2019,46(7):124-127.
[12] 郑哲,张国龙,王秀丽.单线态氧在光动力治疗中的作用机制及检测方法[J].中国激光医学杂志,2019,28(4):219-223.
[13] Misba L, Zaidi S, Khan AU. Efficacy of photodynamic therapy against Streptococcus mutans,biofilm: Role of singlet oxygen[J]. J Photochem Photobiol B, 2018, 183:16-21.
[14] Kim MM, Penjweini R, Gemmell NR, et al. A comparison of singlet oxygen explicit dosimetry(SOED)and singlet oxygen luminescence dosimetry(SOLD)for photofrin-mediated photodynamic therapy[J]. Cancers (Basel), 2016, 8(12):109.
[15] 董毅,曾昕,陈谦明.光动力治疗与口腔粘膜白斑病[J].临床口腔医学杂志,2005,21(7):442-443.
[16] Ethirajan M, Chen Y, Joshi P, et al. The role of porphyrin chemistry in tumor imaging and photodynamic therapy[J]. Chem Soc Rev, 2010, 40(1):340-362.
[17] Bonnet S. Shifting the light activation of metallodrugs to the red and near-infrared region in anticancer phototherapy[J]. Comments Inorg Chem, 2015, 35:179-213.
[18] 刘宏伟.光动力疗法在口腔黏膜病治疗中的应用[J].中国口腔医学继续教育杂志,2019,22(6):353-357.
[19] Kawczyk-Krupka A, Wakowska J, Raczkowska-Siostrzonek A, et al. Comparison of cryotherapy and photodynamic therapy in treatment of oral leukoplakia[J]. Photodiagnosis Photodyn Ther, 2012, 9(2):148-155.
[20] Maloth KN, Velpula N, Kodangal S, et al. Photodynamic therapy-a non-invasive treatment modality for precancerous lesions[J]. J Lasers Med Sci, 2016, 7(1):30-36.
[21] Shafirstein G, Friedman A, Siegel E, et al. Using 5-aminolevulinic acid and pulsed dye laser for photodynamic treatment of oral leukoplakia[J]. Arch Otolaryngol Head Neck Surg, 2011, 137(11):1117-1123.
[22] Han Y, Xu S, Jin J, et al. Primary clinical evaluation of photodynamic therapy with oral leukoplakia in Chinese patients[J]. Front Physiol, 2019, 22(9): 1911.
[23] Yu CH, Chen HM, Hung HY, et al. Photodynamic therapy outcome for oral verrucous hyperplasia depends on the clinical appearance, size, color, epithelial dysplasia, and surface keratin thickness of the lesion[J]. Oral Oncol, 2008, 44(6):595-600.
[24] Togsverd-Bo K, Haak CS, Thaysen-Petersen D, et al. Intensified photodynamic therapy of actinic keratoses with fractional CO₂ laser: a randomized clinical trial[J]. Br J Dermatol, 2012, 166(6):1262-1269.
[25] Wang X, Han Y, Jin J, et al. Plum-blossom needle assisted photodynamic therapy: The therapy option for the treatment of oral potentially malignant disorder in the elderly[J]. Photodiagnosis Photodyn Ther, 2019, 25(3):296-299.
[26] Jin X, Xu H, Deng J, et al. Photodynamic therapy for oral potentially malignant disorders[J]. Photodiagnosis Photodyn Ther, 2019, 28: 146-152.
[27] Fan KF, Hopper C, Speight PM, et al. Photodynamic therapy using 5-aminolevulinic acid for premalignant and malignant lesions of the oral cavity[J]. Cancer, 2015, 78(7):1374-1383.
[28] Chen HM, Yu CH, Tu PC, et al. Successful treatment of oral verrucous hyperplasia and oral leukoplakia with topical 5-aminolevulinic acid-mediated photodynamic therapy[J]. Lasers Surg Med, 2005, 37(2):114-122.
[29] Kübler A, Haase T, Rheinwald M, et al. Treatment of oral leukoplakia by topical application of 5-aminolevulinic acid[J]. Int J Oral Maxillofac Surg, 1998, 27(6):466-469.
[30] Selvam NP, Sadaksharam J, Singaravelu G, et al. Treatment of oral leukoplakia with photodynamic therapy: A pilot study[J]. J Cancer Res Ther, 2015, 11(2):464-467.
[31] Prasanna SW, Ingle E, Aruna PR, et al. Photodynamic therapy of oral leukoplakia and oral lichen planus using methylene blue: A pilot study[J]. J Innov Opt Health SCI, 2015, 811(1):1540005.
[32] Pietruska M , Sobaniec S, Bernaczyk P ,et al. Clinical evaluation of photodynamic therapy efficacy in the treatment of oral leukoplakia[J]. Photodiagnosis Photodyn Ther, 2014, 11(1):34-40.
[33] Chen HM, Yu CH, Tsai T, et al. Topical 5-aminolevulinic acid-mediated photodynamic therapy for oral verrucous hyperplasia, oral leukoplakia and oral erythroleukoplakia[J]. Photodiagnosis Photodyn Ther, 2007, 4(1):44-52.

光动力疗法治疗口腔白斑疗效影响因素研究进展

Research Progress on Factors Influencing the Curative Effect of Photodynamic Therapy for Oral Leukoplakia

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 10

编辑推荐

Metrics

[1]	李爽, 胡敏. 关于正畸固定矫治中牙釉质脱矿的研究进展[J]. 口腔医学研究, 2021, 37(8): 685-688.
[2]	全璐璐, 李雪微, 赵俊杰, 邓文振, 张旭, 董伟, 梁永强. 正畸改性流动树脂的体外研究[J]. 口腔医学研究, 2021, 37(8): 712-716.
[3]	杨柳青, 王博灏, 谢立莉. EGCG改性牙科粘接剂的抗菌研究[J]. 口腔医学研究, 2021, 37(2): 131-134.
[4]	高昕, 程英杰, 崔建通, 甘典, 王新文. 光动力治疗口腔黏膜多发性乳头状瘤1例[J]. 口腔医学研究, 2021, 37(2): 179-180.
[5]	韦帝远, 闫志敏. 光动力疗法在口腔念珠菌病中的应用前景及研究进展[J]. 口腔医学研究, 2020, 36(12): 1087-1090.
[6]	张蕾, 姚丽萍, 孟磊. PDT联合Er:YAG激光防龋性及抗酸性的动物实验研究[J]. 口腔医学研究, 2019, 35(10): 961-965.
[7]	邵明敬,王赫,董丽,张红超,刘旭,孟培松. 芦荟大黄素纳米脂质体介导的光动力疗法对人舌鳞状细胞癌细胞Tca-8113治疗效果的研究[J]. 口腔医学研究, 2018, 34(9): 948-951.
[8]	黄宇思, 张磊, 刘乐天, 马垚, 刘鑫. 华卟啉钠介导的光动力疗法对人舌鳞癌细胞株HSC-4的增殖和迁移能力的影响[J]. 口腔医学研究, 2018, 34(11): 1208-1211.
[9]	张红超,刘云青,邵明敬,王翠萍,毕良佳,孟培松. AE-PDT对裸鼠舌鳞癌治疗效果的初步探讨[J]. 口腔医学研究, 2017, 33(12): 1266-1269.
[10]	侯佳, 陶洪. 光动力疗法对II型糖尿病患者合并慢性牙周炎的治疗效果[J]. 口腔医学研究, 2016, 32(10): 1067-1069.